Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 66, Issue 6, Pages 1934-1951
Publisher
Wiley
Online
2017-07-17
DOI
10.1002/hep.29372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-organ Mapping of Cancer Risk
- (2016) Liqin Zhu et al. CELL
- Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
- (2015) Tung-Hung Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
- (2015) X Zhao et al. Cell Death & Disease
- Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity
- (2014) R. Pincheira et al. JOURNAL OF IMMUNOLOGY
- A preventable cancer
- (2014) Lucas Laursen NATURE
- Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells
- (2013) Kuancan Liu et al. Cell Stem Cell
- Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
- (2013) Ágnes Holczbauer et al. GASTROENTEROLOGY
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
- (2013) Olivier Govaere et al. GUT
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition
- (2013) L Guo et al. ONCOGENE
- p28GANK Prevents Degradation of Oct4 and Promotes Expansion of Tumor-Initiating Cells in Hepatocarcinogenesis
- (2012) You–Wen Qian et al. GASTROENTEROLOGY
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
- (2012) Kun Wu et al. HEPATOLOGY
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
- (2011) Olga A. Guryanova et al. CANCER CELL
- CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
- (2011) Terence Kin Wah Lee et al. Cell Stem Cell
- Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
- (2011) Wen Sun et al. HEPATOLOGY
- Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis
- (2011) Haeryoung Kim et al. HEPATOLOGY
- FAT10 mediates the effect of TNF- in inducing chromosomal instability
- (2011) J. Ren et al. JOURNAL OF CELL SCIENCE
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Inflammation and Liver Cancer
- (2009) C. Berasain et al. Annals of the New York Academy of Sciences
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- A mechanism linking extra centrosomes to chromosomal instability
- (2009) Neil J. Ganem et al. NATURE
- Liver Cancer Stem Cells
- (2008) Stewart Sell et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started